Search by Journal
- HOME
- > Search by Journal
- > Artificial Blood
Artificial Blood
Volume 23, Issue 1 / 2015
English Article Japanese Article
- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
It is "... great chairperson greetings from annual conference innovation - foundations of blood substitute to clinical practice" the 22nd Japan blood substitute association 丸山徹 Artificial Blood 23(1): 3-3, 2015. |
The drug discovery development that assumed the structure, function properties of the α1-acidity glycoprotein a base 丸山徹1,2 Artificial Blood 23(1): 11-11, 2015. |
Significance ... of CKD and metabolic syndrome ... heart kidney metabolism linkage and the biomarker 向山政志 Artificial Blood 23(1): 12-12, 2015. |
Hormonal therapies - taking a lesson from the past - for the breast cancer 岩瀬弘敬 Artificial Blood 23(1): 13-13, 2015. |
From artificial red blood cells to cerebral infarction therapeutic drug development 奥直人 Artificial Blood 23(1): 14-14, 2015. |
Thing to connect inflammatory effect - menstruation and condition of a patient of the prostaglandin to 杉本幸彦 Artificial Blood 23(1): 15-15, 2015. |
A Hemoglobin And Superoxide Taming Drug That Makes Crystalloid An Alternative to Blood Transfusion Carleton J.C. Hsia Artificial Blood 23(1): 16-16, 2015. |
Study aiming at practical use of storage, the artificial red blood cells preparation which is available for urgent administration 酒井宏水1, 小田切優樹2, 東寛3, 木下学4, 高瀬凡平4, 河野光智5, 岩本美智子6, 堀之内宏久7, 高折益彦8, 小林紘一9 Artificial Blood 23(1): 17-17, 2015. |
About the pharmacologic action of the lipid two folds membrane constituting artificial red blood cells (hemoglobin endoplasmic reticulum) 東寛1, 吉田陽一郎1, 高橋弘典1, 高橋大輔2, 藤原満博2, 酒井宏水3 Artificial Blood 23(1): 18-18, 2015. |
It is ... from internal behavior and safety assessment - normalcy of the cells type person mechanic oxygen paratenesis hemoglobin endoplasmic reticulum to the condition of a patient 小田切優樹1, 田口和明1, 丸山徹2, 酒井宏水3 Artificial Blood 23(1): 19-19, 2015. |
Effect of the artificial oxygen paratenesis on arrhythmogenicity of the hemorrhagic shock heart 高瀬凡平1, 田中良弘2, 橋本賢一1, 東村悠子1 Artificial Blood 23(1): 20-20, 2015. |
It is tried the revival by artificial red blood cells for hemorrhagic shock with the coagulation disorder 朝比奈はるか1, 萩沢康介2, 木下学3, 酒井宏水4, 斎藤大蔵5 Artificial Blood 23(1): 21-21, 2015. |
Effect to give to hemodynamics and blood oxygenation of the hemoglobin endoplasmic reticulum administration in the bleeding model for the rat pneumonectomy perioperative period 河野光智1, 松田信作2, 神山育男2, 堀之内宏久3, 渡辺真純2, 酒井宏水4, 小林紘一2, 岩崎正之1 Artificial Blood 23(1): 22-22, 2015. |
Examination about the usefulness at ventilatory failure of the hemoglobin endoplasmic reticulum 内藤祐介1, 井上聡己1, 酒井宏水2, 川口昌彦1 Artificial Blood 23(1): 23-23, 2015. |
Artificial oxygen paratenesis "HemoAct(TM) Study development for the practical use of " 小松晃之 Artificial Blood 23(1): 24-24, 2015. |
Control of development and the oxygen affinity of hemoglobin artificial red blood cells derived from albumin/pig 伊藤大知1,2, 松浦麻衣1, Yao-Tong Lai1, 太田誠一2, 赤松憲樹3, 中尾真一3, 酒井康行4 Artificial Blood 23(1): 25-25, 2015. |
Improvement of blood retentivity by the combination to the serum albumin surface of artificial oxygen paratenesis HemoCD 北岸宏亮 Artificial Blood 23(1): 26-26, 2015. |
Development of the artificial blood for the dog 山田佳奈, 秋山元英, 小松晃之 Artificial Blood 23(1): 27-27, 2015. |
Creation of the blood stay type thioredoxin that assumed an albumin fusion technology a base and application to acute renal failure treatment 渡邊博志1,2, 異島優1,2, 小田切優樹3,4, 丸山徹1,2 Artificial Blood 23(1): 28-28, 2015. |
The need and the prospects of the artificial platelet in the emergency care 木下学1, 萩沢康介2, 朝比奈はるか3, 田中良弘3, 斎藤大蔵4, 高瀬凡平5 Artificial Blood 23(1): 29-29, 2015. |
Lifesaving effect of H12-ADP-liposome on pulmonary haemorrhage by the laser shock wave 萩沢康介1, 木下学2, 宮脇博基3, 佐藤俊一4, 鈴木英紀5, 多喜川真人6, 武岡真司6, 斎藤大蔵7, 西田育弘1 Artificial Blood 23(1): 30-30, 2015. |
A platelet: A red blood cell: New development of the plasma (1:1:1) revival transfusion 多喜川真人1, 萩沢康介2, 木下学3, 朝比奈はるか4, 斎藤大蔵5, 武岡真司1 Artificial Blood 23(1): 31-31, 2015. |
Image of super minute form at the artificial platelet administration in the rabbit liver and the mouse pulmonary haemorrhage model 鈴木英紀1, 萩沢康介2, 武岡真司3, 半田誠4, 木下学2 Artificial Blood 23(1): 32-32, 2015. |
Internal change properties in the repeated administration of the artificial platelet H12 (ADP) liposome 丸山徹1, 橋本麻衣1,2, 田口和明2 Artificial Blood 23(1): 33-33, 2015. |
The refinement and the oxygen affinity measurement with high efficiency of HemoAct(TM) 岩崎瞳, 船木亮佑, 篠原隆一, 小松晃之 Artificial Blood 23(1): 34-34, 2015. |
Composition and oxygen binding capacity of HemoAct(TM) using the pig hemoglobin 横幕恭子, 小松晃之 Artificial Blood 23(1): 35-35, 2015. |
1-G3. Study of amino acid-containing cationic liposomes on the immune stimulation of human macrophages and THP-1 monocytes Tianshu LI1, Shinji TAKEOKA1,2 Artificial Blood 23(1): 36-36, 2015. |
Basic examination of the albumin preparation prescription: About usefulness of the N-acetyl methionine as the antioxidant 河野陽介1,4, 安楽誠1, 山崎啓之1,2, 丸山徹3, 岡山善郎4, 平山文俊1,2, 小田切優樹1,2 Artificial Blood 23(1): 37-37, 2015. |
The artificial red blood cells take the role as the sensitizer of the port-wine stain dye laster treatment 力久直昭1, 佐藤兼重2, 酒井宏水3 Artificial Blood 23(1): 38-38, 2015. |
The effect that the hemoglobin endoplasmic reticulum revival gives for transfusion-associated acute pulmonary disorder 得能正裕1, 田口和明1, 山崎啓之1, 酒井宏水2, 小田切優樹1 Artificial Blood 23(1): 39-39, 2015. |
Construction of the magnetic particle connotation platelet substitute H12- (ADP/mp) liposome 大澤史佳, 武岡真司 Artificial Blood 23(1): 40-40, 2015. |
Inhibitory effect of hydroxypropyl-β-cyclodextrin/fullerene nanoparticles for the acetaminophen-induced liver damage 梅崎至高1, 庵原大輔1, 安楽誠1,2, 上釜兼人2, 平山文俊1,2 Artificial Blood 23(1): 41-41, 2015. |
A design of blood stay type albumin fusion BMP7 and evaluation of the sustained kidney protection 戸田翔太1, 渡邊博志1,2, 異島優1,2, 小田切優樹3,4, 丸山徹1,2 Artificial Blood 23(1): 42-42, 2015. |
Efficiency of the high polymer anticancer agent treatment using the nitric oxide addition albumin dimer which is new nanoEPR enhancer 木下遼1, 異島優1, 池田真由美1, 方軍2, 前田浩2, 渡邊博志1, 小田切優樹2, 丸山徹1 Artificial Blood 23(1): 43-43, 2015. |
Usefulness evaluation of the carbon monoxide for the inflammatory bowel disease conjugate hemoglobin endoplasmic reticulum 永尾紗理1, 田口和明2, 酒井宏水3, 小田切優樹2, 丸山徹1 Artificial Blood 23(1): 44-44, 2015. |
Usefulness evaluation of the carbon monoxide addition red blood cell for the rhabdomyolysis-induced renal failure model rat 大柿滋1, 田口和明2, 異島優1, 渡邊博志1, 小田切優樹2, 丸山徹1 Artificial Blood 23(1): 45-45, 2015. |
Development of Perfusate for Tissue/Organ Preservation with Artificial Oxygen-Carrying Hemoglobin Vesicles Jun Araki(1), Hiromi Sakai(2), Dai Takeuchi(3), Isao Koshima(1) Artificial Blood 23(1): 47-51, 2015. |